CLVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient investor: price is in a strong downtrend (bearish MAs + negative/expanding MACD), and there are no Intellectia buy signals to justify stepping in early.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently.", "Oversold RSI (6.5) raises the odds of a short-lived bounce, but this is a low-quality setup without confirmation; the path of least resistance remains down.", "Street view has deteriorated (downgrades to Neutral/Underweight citing slow growth + AI-native competition), which typically caps near-term upside despite the low absolute share price.", "If you must act immediately, the data supports avoiding new longs now rather than buying into a falling trend ahead of earnings."]
["Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating sustained downside momentum across long/medium/short timeframes.", "Momentum: MACD histogram -0.0642 and negatively expanding \u2192 bearish momentum is strengthening, not stabilizing.", "RSI: RSI_6 = 6.499 (extremely oversold) \u2192 elevated probability of a reflex rally, but oversold can persist in strong downtrends.", "Key levels: Pivot 2.602 is far above current price (2.035), confirming price is below key equilibrium; near support S2 ~2.052 is being tested/broken, implying weak support structure.", "Pattern-based odds: Similar-candlestick model suggests a modest bounce probability (next day +1.47%, next week +2.55%, next month +8.92%), but this conflicts with the current dominant bearish trend signals."]
["Debt/capital structure improvement: Redeemed remaining $100M of 4.50% senior secured notes using cash on hand \u2192 simplified structure and improved flexibility.", "Shareholder returns: Q4 2025 repurchased ~21M shares for $75M; $225M for the year \u2192 supportive of per-share optics and indicates capital allocation discipline.", "Earnings catalyst: Q4/FY2025 results on 2026-02-24 (pre-market) could create a sharp move if results/guidance surprise positively.", "Flows: Hedge funds net buying increased 182.82% QoQ \u2192 some institutional accumulation signal."]
["Latest reported quarter: 2025/Q3.", "Revenue: $623.1M, +0.14% YoY \u2192 essentially flat growth (no clear re-acceleration).", "Net income: -$28.3M, -56.86% YoY \u2192 losses widened meaningfully.", "EPS: -$0.04, -55.56% YoY \u2192 per-share performance deteriorated.", "Gross margin: 34.2%, -9.40% YoY \u2192 significant margin compression, a key negative trend for a turnaround narrative."]
["Recent trend: Ratings/targets moved down (bearish shift).", "2026-01-08 Goldman Sachs: Downgraded to Neutral from Buy; PT cut to $3.60 from $4.20, citing extended timeline for the Value Creation Plan and slower growth due to AI-native competition and limited pricing power.", "2025-12-17 Morgan Stanley: Downgraded to Underweight from Equal Weight; PT cut to $3 from $5, citing a struggling turnaround, tight budgets, and limited value from strategic review.", "Wall Street pros: Capital allocation actions (buybacks/debt reduction) and low price vs targets could support rebound narratives.", "Wall Street cons: Core growth challenges + competitive pressure + margin deterioration \u2192 skepticism that improvements arrive soon."]
